Innoviva, Inc. (INVA): EPS (Diluted)
$3.30
Year ended 2025-12-31
+11.7%
3-year compound annual growth
+10.3%
5-year compound annual growth
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.30 | +816.7% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $0.36 | -83.6% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $2.20 | -7.2% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $2.37 | -17.4% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $2.87 | +42.1% | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | $2.02 | +41.3% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $1.43 | -59.5% | 2022-03-17, From 2019-01-01 |
| 2018-12-31 | $3.53 | +201.7% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $1.17 | +120.8% | 2020-02-19, From 2017-01-01 |
| 2016-12-31 | $0.53 | n/m | 2019-02-19, From 2016-01-01 |
| 2015-12-31 | -$0.16 | n/m | 2018-02-23, From 2015-01-01 |
| 2014-12-31 | -$1.50 | n/a | 2017-02-28, From 2014-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Innoviva, Inc. (INVA) | 2025-12-31 | $3.30 | +816.7% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$0.26 | n/m |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | -$0.83 | n/m |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | -$0.13 | n/m |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | -$0.16 | n/m |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $1.06 | +165.0% |
| MannKind Corp (MNKD) | 2025-12-31 | $0.02 | -80.0% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | -$0.29 | n/m |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | -$3.78 | n/m |
Compare INVA, ARDX, SVA, ARQT side by side · Screen every company in Pharmaceutical Preparations ↗